日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy of parainfluenza virus 5 (PIV5)-vectored intranasal COVID-19 vaccine as a single dose primer and booster against SARS-CoV-2 variants.

副流感病毒 5 (PIV5) 载体鼻内 COVID-19 疫苗作为单剂量启动剂和加强剂对抗 SARS-CoV-2 变种的功效

Beavis Ashley C, Li Zhuo, Briggs Kelsey, Gingerich María Cristina, Wrobel Elizabeth R, Najera Maria, An Dong, Orr-Burks Nichole, Murray Jackelyn, Patil Preetish, Huang Jiachen, Mousa Jarrod, Hao Linhui, Hsiang Tien-Ying, Gale Michael Jr, Harvey Stephen B, Tompkins S Mark, Hogan Robert Jeffrey, Lafontaine Eric R, Jin Hong, He Biao

A parainfluenza virus 5 (PIV5)-vectored intranasal SARS-CoV-2 vaccine (CVXGA1) elicits protective and long-lasting immunity in nonhuman primates.

以副流感病毒 5 (PIV5) 为载体的鼻内 SARS-CoV-2 疫苗 (CVXGA1) 可在非人灵长类动物中诱导产生保护性和持久的免疫力

Beavis Ashley C, Xiao Peng, Gingerich Maria Cristina, Briggs Kelsey, Li Geng, Howerth Elizabeth W, Najera Maria, An Dong, Huang Jiachen, Mousa Jarrod, Tompkins S Mark, Kim Gina, Harvey Stephen B, Hogan Robert Jeffrey, Lafontaine Eric R, Villinger Francois J, Jin Hong, He Biao

Cleavage of the syncytial protein of J paramyxovirus is required for its ability to promote cell-cell fusion.

J 副粘液病毒合胞体蛋白的裂解是其促进细胞融合所必需的

An Dong, Li Zhuo, Beavis Ashley C, Briggs Kelsey R, Harvill Mason, He Biao

Morphologic characterization and cytokine response of chicken bone-marrow derived dendritic cells to infection with high and low pathogenic avian influenza virus

鸡骨髓来源树突状细胞感染高致病性和低致病性禽流感病毒后的形态学特征和细胞因子反应

Mo, Jongsuk; Segovia, Karen; Chrzastek, Klaudia; Briggs, Kelsey; Kapczynski, Darrell R

Comparative analysis of PB2 residue 627E/K/V in H5 subtypes of avian influenza viruses isolated from birds and mammals

对从鸟类和哺乳动物中分离的禽流感病毒H5亚型中PB2残基627E/K/V的比较分析

Briggs, Kelsey; Kapczynski, Darrell R

Immunogenicity of Mumps Virus Genotype G Vaccine Candidates in Jeryl Lynn-Immunized Mice

腮腺炎病毒G基因型候选疫苗在杰瑞尔·林恩免疫小鼠中的免疫原性

Briggs, Kelsey; Kirby, Cara; Beavis, Ashley C; Zengel, James; Patil, Preetish; Sauder, Christian; He, Biao

Efficacy of Parainfluenza Virus 5 (PIV5)-vectored Intranasal COVID-19 Vaccine as a Single Dose Vaccine and as a Booster against SARS-CoV-2 Variants.

副流感病毒 5 (PIV5) 载体鼻内 COVID-19 疫苗作为单剂量疫苗和针对 SARS-CoV-2 变种的加强疫苗的功效

Beavis Ashley C, Li Zhuo, Briggs Kelsey, Huertas-Díaz María Cristina, Wrobel Elizabeth R, Najera Maria, An Dong, Orr-Burks Nichole, Murray Jackelyn, Patil Preetish, Huang Jiachen, Mousa Jarrod, Hao Linhui, Hsiang Tien-Ying, Gale Michael Jr, Harvey Stephen B, Tompkins S Mark, Hogan Robert Jeffrey, Lafontaine Eric R, Jin Hong, He Biao